This website offers cannabis information and is restricted to adults aged 19 years and older.

Please enter your birthdate to confirm you are at least 19 years of age.

CannTx Life Sciences Inc. Receives Licence to Sell Cannabis from Health Canada

PUSLINCH, Ontario Canada, May 13, 2020 – CannTx Life Sciences Inc. ("CannTx" or, the "Company")a private cannabis company located in Puslinch, Ontario is pleased to announce that it has received its sales amendment from Health Canada to sell dried and fresh cannabis products for recreational use (the “Sales Licence”). With the receipt of the Sales Licence, CannTx is now able to directly sell its premium quality flower to all provincial and territorial distributors.
 
“Today is an incredible and important milestone for the CannTx Life Sciences team as we continue our journey to produce and supply the Canadian Cannabis market with premium quality flower.” stated Mike Abbott, President/CEO & Co-Founder. “This Sales Licence allows us to launch a full portfolio of brands including Royal City Cannabis Co. in provinces like Ontario, British Columbia and Saskatchewan.
 
About CannTx Life Sciences Inc.
CannTx Life Sciences Inc. is a privately-owned cannabis producer, with exceptional biotechnology and horticulture capabilities. Founded in 2013, CannTx operates a 30,000 sq. ft. facility, just south of Guelph ON, under both a Standard Cultivation and Standard Processing authorization from Health Canada.
 
CannTx’s commercial-scale in vitro plant tissue culture lab, Biosafety Laboratory Level 2 microbiology lab, 8 precision-controlled growth environs for flower production, and photobiology lab for crop optimization supports CannTx’s talented 50+ person team, a third of which possess a science related degree. Combined, the CannTx team leverages 7 PhD’s, 11 Masters degrees and close to 100 years of cannabis cultivation experience to drive innovation, advance the deployment of new technologies, and partner with private and public research institutions for commercial benefit.
 
CannTx’s tissue culture capabilities diversify its revenue opportunities through its Steadystem Solutions division, providing germplasm cleaning, validation, storage, and propagation services to other cannabis cultivators and breeders. Leveraging local analytics service providers, paired with our efficient and productive cannabis cultivation operations and its growing in vitro library of clean strains, CannTx is uniquely positioned to provide the most robust suite of germplasm validation services, and a superior platform for germplasm commercialization.
 
Contact
Mike Abbott, CEO/President and Co-Founder

mike.abbott@canntx.com
519-589-2952